Stark omsättning, men orderingång åt det svagare hållet Nettoomsättningen för Q4 2022 uppgick till 8...
A company undergoing transformation Since Starboard became the main shareholder of Maha at the end o...
Fellow Bank has met the expectations that were set out for 2022.
Redeye reinforces its positive view of ADDvise following strong preliminary Q4 figures.
Solid Q4 top-line, but margins fail to reach expectations FY'23 guidance indicates a soft margin exp...
For yet another quarter, Nexam was hurt by slow demand in the wind power industry.
Q4 report on Thursday, 16 February Stronger winds, but again below budget EBIT of SEK 51m, with a ma...
Q4 report due on Thursday, 16 February Sale of Centennial Flats expected to be the main EBIT driver ...
LL Lucky Games meddelade den 30 januari att bolagsstämman beslutat om genomförandet av den tidigare ...
Redeye updates its view on the lawsuit with a new schedule and an updated view on the number of unit...
Redeye makes slight estimate changes ahead of the Q4 report (due 10th of February).
Redeye leaves a comment on Faron Pharmaceutical's recent private placement.
Redeye raises its Base Case slightly following the positive conclusion of the phase I trial with laq...
Redeye is pleased to note that Lifeclean did a direct issue of SEK 27m after costs this morning.
BankNordik has announced 2023 net profit guidance of DKK 190-220m, alongside a revision of its 2024 ...
Cons. expects FY'22 org growth of 3.8% vs. guidance of 4-6% China reopening likely not a major cons.
Q4 estimate changes Q4'22e is likely to be similar to Q3 in a few ways, with a gross margin below 20...
Svagt kvartal, utdelning bör ge stöd till aktien BE Group rapporterade en underliggande Q4’22 EBIT p...
Major profit warning on component shortages, see SEK 9m in Q4 EBIT Clearly below ABGSCe, likely mate...
Suominen reports Q4 results on Feb 3. It’s clear Q4 will be a lot better than previous quarters, whi...
